SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: li3511 who wrote (63260)9/30/2025 12:56:06 PM
From: stockdoc772 Recommendations

Recommended By
bodish
erippetoe

   of 63276
 
He also took a swipe at SRPT wrongly insinuating that its exon skippers failed their confirmatory trials. Those trials are ongoing and 2 of 3 exon skippers will report in Q4. The last one will report next year. Must also consider that moms who have kids on these agents for 5 or more years can obviously tell if they are changing the natural history of DMD. If the drugs were not working they would stop them. They require monthly IV infusions so are burdensome.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News